Effects of dietary macronutrient distribution on vascular integrity in obesity and metabolic syndrome

Nutrition Reviews

Volumn 69, Issue 9, 2011, Pages 509-519

  Gregory, Sara M ^a   Headley, Samuel A ^a   Wood, Richard J ^a  

^a SPRINGFIELD COLLEGE   (United States)

Author keywords

Arterial stiffness; Macronutrient redistribution; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AEROBIC EXERCISE; ARTERIAL STIFFNESS; ARTICLE; BLOOD FLOW; BLOOD VESSEL FUNCTION; BLOOD VESSEL PARAMETERS; CARDIOVASCULAR RISK; ENDOTHELIAL DYSFUNCTION; HUMAN; KETOACIDOSIS; LOW CARBOHYDRATE DIET; LOW FAT DIET; MACRONUTRIENT; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PULSE WAVE; VASCULAR INTEGRITY; WEIGHT REDUCTION;

ANIMALS; DIET, REDUCING; HUMANS; METABOLIC SYNDROME X; OBESITY; VASCULAR DISEASES; VASCULAR STIFFNESS;

EID: 80052373566     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2011.00390.x     Document Type: Article

References (64)

1. Ford ES, Zhao G, Li C, Pearson WS, Mokdad AH. Trends in obesity and abdominal obesity among hypertensive and nonhypertensive adults in the United States. Am J Hypertens. 2008;21:1124-1128.
2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
3. Mottillo S, Filion KB, Genest J, etal. The metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113-1132.
4. Reaven GM. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr. 2005;25:391-406.
5. Gami AS, Witt BJ, Howard DE, etal. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403-414.
6. Cannon CP. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications. Am J Cardiol. 2008;102:5L-9L.
7. Reynolds K, Wildman RP. Update on the metabolic syndrome: hypertension. Curr Hypertens Rep. 2009;11:150-155.
8. Mikhail N. The metabolic syndrome: insulin resistance. Curr Hypertens Rep. 2009;11:156-158.
9. Phillips LK, Prins JB. The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep. 2008;10:156-164.
10. Greenwald SE. Ageing of the conduit arteries. J Pathol. 2007;211:157-172.
11. Maeda S, Iemitsu M, Miyauchi T, Kuno S, Matsuda M, Tanaka H. Aortic stiffness and aerobic exercise: mechanistic insight from microarray analyses. Med Sci Sports Exerc. 2005;37:1710-1716.
12. Kingwell BA, Gatzka CD. Arterial stiffness and prediction of cardiovascular risk. J Hypertens. 2002;20:2337-2340.
13. O'Rourke MF, Staessen JA. Clinical applications of arterial stiffness; definition and reference values. Am J Hypertens. 2002;15:426-444.
14. Wimmer NJ, Townsend RR, Joffe MM, Lash JP, Go AS. Correlation between pulse wave velocity and other measures of arterial stiffness in chronic kidney disease. Clin Nephrol. 2007;68:133-143.
15. Woodman RJ, Watts GF. Measurement and application of arterial stiffness in clinical research: focus on new methodologies and diabetes mellitus. Med Sci Monit. 2003;9:RA81-RA89.
16. Covic A, Haydar AA, Bhamra-Ariza P, Gusbeth-Tatomir P, Goldsmith DJ. Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol. 2005;18:388-396.
17. Sigrist M, Taal MW, Bungay P, McIntyre CW. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol. 2007;2:1241-1248.
18. Hirata K, Kawakami M, O'Rourke MF. Pulse wave analysis and pulse wave velocity. Circ J. 2006;70:1231-1239.
19. Nelson MR, Stepanek J, Cevette M, Covalciuc M, Hurst RT, Tajik AJ. Noninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform? Mayo Clin Proc. 2010;85:460-472.
20. Wilkinson IB, Hall IR, MacCallum E, etal. Pulse wave analysis: clinical evaluation of a non-invasive widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol. 2002;22:147-152.
21. Peretz A, Leotta DF, Sullivan JH, etal. Flow-mediated dilation of the brachial artery: an investigation of methods requiring further standardization. BMC Cardiovasc Disord. 2007;7. Published online 2007 March 21. doi: 10.1186/1471-2261-7-11.
22. Della-Morte D, Gardener H, Denaro F, etal. Metabolic syndrome increases carotid artery stiffness: the Northern Manhattan Study. Int J Stroke. 2010;5:138-144.
23. Xu L, Jiang CQ, Lam TH, etal. The metabolic syndrome is associated with subclinical atherosclerosis independent of insulin resistance: the Guangzhou Biobank Cohort Study-CVD. Clin Endocrinol (Oxf). 2010;73:181-188.
24. Krauss RM, Eckel RH, Howard B, etal. AHA Dietary Guidelines. Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation. 2000;102:2284-2299.
25. Feinman RD, Volek JS. Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome. Scand Cardiovasc J. 2008;42:256-263.
26. Volek JS, Westman EC. Very-low-carbohydrate weight-loss diets revisited. Cleve Clin J Med. 2002;69:849-862.
27. Wood RJ. Effect of dietary carbohydrate restriction with and without weight loss on atherogenic dyslipidemia. Nutr Rev. 2006;64:539-545.
28. Al-Sarraj T, Saadi H, Calle MC, Volek JS, Fernandez ML. Carbohydrate restriction, as a first-line dietary intervention, effectively reduces biomarkers of metabolic syndrome in Emirati adults. J Nutr. 2009;139:1667-1676.
29. Wood RJ, Volek JS, Davis SR, Dell'Ova C, Fernandez ML. Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease. Nutr Metab (Lond). 2006;3. Published online 2006 May 4. doi: 10.1186/1743-7075-3-19.
30. Keogh JB, Brinkworth GD, Clifton PM. Effects of weight loss on a low-carbohydrate diet on flow-mediated dilatation, adhesion molecules and adiponectin. Br J Nutr. 2007;98:852-859.
31. Volek JS, Fernandez ML, Feinman RD, Phinney SD. Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome. Prog Lipid Res. 2008;47:307-318.
32. US Department of Agriculture and US Department of Health and Human Services. Dietary Guidelines for Americans, 2010, 7th ed. Washington, DC, US Government Printing Office, December 2010.
33. Wycherley TP, Brinkworth GD, Keogh JB, Noakes M, Buckley JD, Clifton PM. Long-term effects of weight loss with a very-low-carbohydrate and low-fat diet on vascular function in overweight and obese patients. J Intern Med. 2010;267:452-461.
34. Seshadri P, Iqbal N, Stern L, etal. A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am J Med. 2004;117:398-405.
35. Miyaki A, Maeda S, Yoshizawa M, etal. Effect of weight reduction with dietary intervention on arterial distensibility and endothelial function in obese men. Angiology. 2009;60:351-357.
36. Keogh JB, Brinkworth GD, Noakes M, Belobrajdic DP, Buckley JD, Clifton PM. Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr. 2008;87:567-576.
37. Iannuzzi A, Licenziati MR, Vacca M, etal. Comparison of two diets of varying glycemic index on carotid subclinical atherosclerosis in obese children. Heart Vessels. 2009;24:419-424.
38. Wolfson N, Garish D, Goldberg Y, Boaz M, Matas Z, Shargorodsky M. Effect of weight loss maintenance on arterial compliance and metabolic and inflammatory parameters: a three-year follow-up study. Ann Nutr Metab. 2010;57:204-210.
39. Ahuja KD, Robertson IK, Ball MJ. Acute effects of food on postprandial blood pressure and measures of arterial stiffness in healthy humans. Am J Clin Nutr. 2009;90:298-303.
40. Phillips LK, Peake JM, Zhang X, etal. The effect of a high-fat meal on postprandial arterial stiffness in men with obesity and type 2 diabetes. J Clin Endocrinol Metab. 2010;95:4455-4459.
41. Volek JS, Ballard KD, Silvestre R, etal. Effects of dietary carbohydrate restriction versus low-fat diet on flow-mediated dilation. Metabolism. 2009;58:1769-1777.
42. Buscemi S, Verga S, Tranchina MR, Cottone S, Cerasola G. Effects of hypocaloric very-low-carbohydrate diet versus Mediterranean diet on endothelial function in obese women. Eur J Clin Invest. 2009;39:339-347.
43. Rubin D, Claas S, Pfeuffer M, Nothnagel M, Foelsch UR. Schrezenmeir J. s-ICAM-1 and s-VCAM-1 in healthy men are strongly associated with traits of the metabolic syndrome, becoming evident in the postprandial response to a lipid-rich meal. Lipids Health Dis. 2008;7:32.
44. Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010;2010. Published online 2010 July 14. doi: 10.1155/2010/289645.
45. Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008;51:527-539.
46. Salmenniemi U, Ruotsalainen E, Pihlajamaki J, etal. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation. 2004;110:3842-3848.
47. Barbato JE, Zuckerbraun BS, Overhaus M, Raman KG, Tzeng E. Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome. Am J Physiol Heart Circ Physiol. 2005;289:H228-H236.
48. Barbato JE, Zuckerbraun BS, Overhaus M, Raman KG, Tzeng E. Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome. Am J Physiol Heart Circ Physiol. 2005;289:H228-H236.
49. Roberts CK, Won D, Pruthi S, etal. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol. 2006;100:1657-1665.
50. Roberts CK, Ng C, Hama S, Eliseo AJ, Barnard RJ. Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors. J Appl Physiol. 2006;101:1727-1732.
51. Esposito K, Pontillo A, Di Palo C, etal. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289:1799-1804.
52. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol. 2005;98:1154-1162.
53. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615-1625.
54. Raitakari M, Ilvonen T, Ahotupa M, etal. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol. 2004;24:124-128.
55. Rector RS, Warner SO, Liu Y, etal. Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Am J Physiol Endocrinol Metab. 2007;293:E500-E506.
56. Ignarro LJ, Balestrieri ML, Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res. 2007;73:326-340.
57. Madden KM, Lockhart C, Cuff D, Potter TF, Meneilly GS. Short-term aerobic exercise reduces arterial stiffness in older adults with type 2 diabetes, hypertension, and hypercholesterolemia. Diabetes Care. 2009;32:1531-1535.
58. Okada S, Hiuge A, Makino H, etal. Effect of exercise intervention on endothelial function and incidence of cardiovascular disease in patients with type 2 diabetes. J Atheroscler Thromb. 2010;17:828-833.
59. Hamdy O, Ledbury S, Mullooly C, etal. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care. 2003;26:2119-2125.
60. Assumpcão CR, Brunini TMC, Matsuura C, Resende AC, Mendes-Ribeiro AC. Impact of the l-arginine-nitric oxide pathway and oxidative stress on the pathogenesis of the metabolic syndrome. Open Biochem J. 2008;2:108-115.
61. Isales CM, Min L, Hoffman WH. Acetoacetate and beta-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. J Diabetes Complications. 1999;13:91-97.
62. Jain SK, Kannan K, Lim G. Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radic Biol Med. 1998;25:1083-1088.
63. Hoffman WH, Cheng C, Passmore GG, Carroll JE, Hess D. Acetoacetate increases expression of intercellular adhesion molecule-1 (ICAM-1) in human brain microvascular endothelial cells. Neurosci Lett. 2002;334:71-74.
64. Stafford P, Abdelwahab MG, Kim do Y, Preul MC, Rho JM, Scheck AC. The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutr Metab (Lond). 2010;7:74.